Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

A mechanistic evaluation of the angiogenic properties of a dehydrated amnion chorion membrane in vitro and in vivo.

McQuilling JP, Burnette M, Kimmerling KA, Kammer M, Mowry KC.

Wound Repair Regen. 2019 Nov;27(6):609-621. doi: 10.1111/wrr.12757. Epub 2019 Aug 29.

PMID:
31425636
2.

Brain Tumor, Pheochromocytoma, and Pregnancy: A Case Report of a Cesarean Delivery in a Patient With Von Hippel-Lindau Disease.

Burnette MS, Mann TS, Berman DJ, Nguyen TT.

A A Pract. 2019 Oct 15;13(8):289-291. doi: 10.1213/XAA.0000000000001049.

PMID:
31206381
3.

Combined Scaffold Evaluation and Systems-Level Transcriptome-Based Analysis for Accelerated Lead Optimization Reveals Ribosomal Targeting Spirooxindole Cyclopropanes.

Rodriguez KX, Howe EN, Bacher EP, Burnette M, Meloche JL, Meisel J, Schnepp P, Tan X, Chang M, Zartman J, Zhang S, Ashfeld BL.

ChemMedChem. 2019 Sep 18;14(18):1653-1661. doi: 10.1002/cmdc.201900266. Epub 2019 Jul 1.

PMID:
31140738
4.

Potassium channel activity controls breast cancer metastasis by affecting β-catenin signaling.

Breuer EK, Fukushiro-Lopes D, Dalheim A, Burnette M, Zartman J, Kaja S, Wells C, Campo L, Curtis KJ, Romero-Moreno R, Littlepage LE, Niebur GL, Hoskins K, Nishimura MI, Gentile S.

Cell Death Dis. 2019 Feb 21;10(3):180. doi: 10.1038/s41419-019-1429-0.

5.

Preclinical study of a Kv11.1 potassium channel activator as antineoplastic approach for breast cancer.

Fukushiro-Lopes DF, Hegel AD, Rao V, Wyatt D, Baker A, Breuer EK, Osipo C, Zartman JJ, Burnette M, Kaja S, Kouzoukas D, Burris S, Jones WK, Gentile S.

Oncotarget. 2017 Dec 4;9(3):3321-3337. doi: 10.18632/oncotarget.22925. eCollection 2018 Jan 9.

6.

Impact and Duration of Brief Surgeon-Delivered Smoking Cessation Advice on Attitudes Regarding Nicotine Dependence and Tobacco Harms for Patients with Peripheral Arterial Disease.

Newhall K, Suckow B, Spangler E, Brooke BS, Schanzer A, Tan TW, Burnette M, Edelen MO, Farber A, Goodney P; VAPOR investigators.

Ann Vasc Surg. 2017 Jan;38:113-121. doi: 10.1016/j.avsg.2016.06.005. Epub 2016 Aug 10.

7.

Toll-like receptor-2 exacerbates murine acute viral hepatitis.

Bleau C, Burnette M, Filliol A, Piquet-Pellorce C, Samson M, Lamontagne L.

Immunology. 2016 Oct;149(2):204-24. doi: 10.1111/imm.12627. Epub 2016 Aug 10.

8.

Smoking cessation counseling in vascular surgical practice using the results of interviews and focus groups in the Vascular Surgeon offer and report smoking cessation pilot trial.

Newhall K, Burnette M, Brooke BS, Schanzer A, Tan T, Flocke S, Farber A, Goodney P; VAPOR Investigators.

J Vasc Surg. 2016 Apr;63(4):1011-7.e2. doi: 10.1016/j.jvs.2015.10.086. Epub 2015 Dec 30.

9.

Spatiotemporal patterning of polyamines in Drosophila development.

Burnette M, Zartman JJ.

Amino Acids. 2015 Dec;47(12):2665-70. doi: 10.1007/s00726-015-2093-z. Epub 2015 Sep 19.

PMID:
26386564
10.

One shot, one kill: the forces delivered by archer fish shots to distant targets.

Burnette MF, Ashley-Ross MA.

Zoology (Jena). 2015 Oct;118(5):302-11. doi: 10.1016/j.zool.2015.04.001. Epub 2015 Jun 18.

PMID:
26153333
11.

Correlations Between Sexual Abuse Histories, Perceived Danger, and PTSD Among Intimate Partner Violence Victims.

Brown J, Burnette ML, Cerulli C.

J Interpers Violence. 2015 Sep;30(15):2709-25. doi: 10.1177/0886260514553629. Epub 2014 Oct 16.

PMID:
25324230
12.

An inverse small molecule screen to design a chemically defined medium supporting long-term growth of Drosophila cell lines.

Burnette M, Brito-Robinson T, Li J, Zartman J.

Mol Biosyst. 2014 Oct;10(10):2713-23. doi: 10.1039/c4mb00155a.

13.

Analysis for stress environment in the alveolar sac model.

Pidaparti RM, Burnette M, Heise RL, Reynolds A.

J Biomed Sci Eng. 2013 Sep;6(9):901-907.

14.

Developmental trajectories of substance use among sexual minority girls: associations with sexual victimization and sexual health risk.

Oshri A, Handley ED, Sutton TE, Wortel S, Burnette ML.

J Adolesc Health. 2014 Jul;55(1):100-6. doi: 10.1016/j.jadohealth.2013.11.009. Epub 2014 Feb 16.

15.

Piloting a psycho-social intervention for incarcerated women with trauma histories: lessons learned and future recommendations.

Liebman RE, Burnette ML, Raimondi C, Nichols-Hadeed C, Merle P, Cerulli C.

Int J Offender Ther Comp Criminol. 2014 Aug;58(8):894-913. doi: 10.1177/0306624X13491073. Epub 2013 Jun 26.

PMID:
23804649
16.

Gender and the development of oppositional defiant disorder: contributions of physical abuse and early family environment.

Burnette ML.

Child Maltreat. 2013 Aug;18(3):195-204. doi: 10.1177/1077559513478144. Epub 2013 Feb 17.

PMID:
23420295
17.

It's not you, it's me: an examination of clinician- and client-level influences on countertransference toward borderline personality disorder.

Liebman RE, Burnette M.

Am J Orthopsychiatry. 2013 Jan;83(1):115-25. doi: 10.1111/ajop.12002.

PMID:
23330629
18.

Comparing the Youth Psychopathic Traits Inventory (YPI) and the Psychopathy Checklist-Youth Version (PCL-YV) among offending girls.

Chauhan P, Ragbeer SN, Burnette ML, Oudekerk B, Reppucci ND, Moretti MM.

Assessment. 2014 Apr;21(2):181-94. doi: 10.1177/1073191112460271. Epub 2012 Oct 3.

PMID:
23034450
19.

Pathways from harsh parenting to adolescent antisocial behavior: a multidomain test of gender moderation.

Burnette ML, Oshri A, Lax R, Richards D, Ragbeer SN.

Dev Psychopathol. 2012 Aug;24(3):857-70. doi: 10.1017/S0954579412000417.

PMID:
22781859
20.

Multilevel approaches toward understanding antisocial behavior: current research and future directions.

Burnette ML, Cicchetti D.

Dev Psychopathol. 2012 Aug;24(3):703-4. doi: 10.1017/S0954579412000314. No abstract available.

PMID:
22781849
21.

Long-term safety profile of belimumab plus standard therapy in patients with systemic lupus erythematosus.

Merrill JT, Ginzler EM, Wallace DJ, McKay JD, Lisse JR, Aranow C, Wellborne FR, Burnette M, Condemi J, Zhong ZJ, Pineda L, Klein J, Freimuth WW; LBSL02/99 Study Group.

Arthritis Rheum. 2012 Oct;64(10):3364-73. doi: 10.1002/art.34564.

22.

Childhood maltreatment histories, alcohol and other drug use symptoms, and sexual risk behavior in a treatment sample of adolescents.

Oshri A, Tubman JG, Burnette ML.

Am J Public Health. 2012 May;102 Suppl 2:S250-7. doi: 10.2105/AJPH.2011.300628. Epub 2012 Mar 8.

23.

Medical informatics in the curriculum: development and delivery of an online elective.

Burnette MH, De Groote SL, Dorsch JL.

J Med Libr Assoc. 2012 Jan;100(1):61-3. doi: 10.3163/1536-5050.100.1.011. No abstract available.

24.

Unmet need of GP services in Pacific people and other New Zealanders.

Pledger MJ, Cumming J, Burnette M, Daubé J.

N Z Med J. 2011 May 13;124(1334):35-45.

PMID:
21946634
25.

Developmental pathways to adolescent cannabis abuse and dependence: child maltreatment, emerging personality, and internalizing versus externalizing psychopathology.

Oshri A, Rogosch FA, Burnette ML, Cicchetti D.

Psychol Addict Behav. 2011 Dec;25(4):634-44. doi: 10.1037/a0023151. Epub 2011 May 2.

26.

In focus: Addressing sharps safety.

Burnette M.

AORN J. 2011 Mar;93(3):C5. No abstract available.

PMID:
21462545
27.

Increasing medication safety.

Burnette M.

AORN J. 2011 Mar;93(3):C1, C8-9. No abstract available.

PMID:
21462544
28.

In focus: AORN’s new recommended practices for preventing DVT.

Burnette M.

AORN J. 2011 Feb;93(2):C5. No abstract available.

PMID:
21365957
29.

Advancing education in a changing health care environment.

Burnette M.

AORN J. 2011 Feb;93(2):C1, C8, C9. No abstract available.

PMID:
21365955
30.

Health service use amongst users of complementary and alternative medicine.

Pledger MJ, Cumming JN, Burnette M.

N Z Med J. 2010 Apr 9;123(1312):26-35. Erratum in: N Z Med J. 2010 Oct 15;123(1324):113.

PMID:
20389315
31.
32.

The association between violence and lifetime suicidal thoughts and behaviors in individuals treated for substance use disorders.

Ilgen MA, Burnette ML, Conner KR, Czyz E, Murray R, Chermack S.

Addict Behav. 2010 Feb;35(2):111-5. doi: 10.1016/j.addbeh.2009.09.010. Epub 2009 Sep 10.

PMID:
19800173
33.

Implementing new modes of governance in the New Zealand health system: an empirical study.

Barnett P, Tenbensel T, Cumming J, Clayden C, Ashton T, Pledger M, Burnette M.

Health Policy. 2009 Dec;93(2-3):118-27. doi: 10.1016/j.healthpol.2009.06.004. Epub 2009 Jul 19.

PMID:
19619914
34.

Childhood abuse and aggression in girls: the contribution of borderline personality disorder.

Burnette ML, Reppucci ND.

Dev Psychopathol. 2009 Winter;21(1):309-17. doi: 10.1017/S0954579409000170.

PMID:
19144235
35.
36.

Women's past-year prostitution status and receipt of substance abuse treatment services.

Burnette ML, Schneider R, Ilgen MA, Timko C.

Psychiatr Serv. 2008 Dec;59(12):1458-61. doi: 10.1176/appi.ps.59.12.1458.

PMID:
19033174
37.

Misdiagnosing the problem: mental health profiles of incarcerated juveniles.

Odgers CL, Burnette ML, Chauhan P, Moretti MM, Reppucci ND.

Can Child Adolesc Psychiatr Rev. 2005 Feb;14(1):26-9.

38.

History of physical or sexual abuse and participation in 12-step self-help groups.

Schneider R, Burnette M, Timko C.

Am J Drug Alcohol Abuse. 2008;34(5):617-25. doi: 10.1080/00952990802308148.

PMID:
18821455
39.

Emotional responses of staff to assault in a pediatric state hospital.

Ryan EP, Aaron J, Burnette ML, Warren J, Burket R, Aaron T.

J Am Acad Psychiatry Law. 2008;36(3):360-8.

PMID:
18802185
40.

Prevalence and health correlates of prostitution among patients entering treatment for substance use disorders.

Burnette ML, Lucas E, Ilgen M, Frayne SM, Mayo J, Weitlauf JC.

Arch Gen Psychiatry. 2008 Mar;65(3):337-44. doi: 10.1001/archpsyc.65.3.337.

PMID:
18316680
41.

Violence perpetration and childhood abuse among men and women in substance abuse treatment.

Burnette ML, Ilgen M, Frayne SM, Lucas E, Mayo J, Weitlauf JC.

J Subst Abuse Treat. 2008 Sep;35(2):217-22. doi: 10.1016/j.jsat.2007.10.002. Epub 2008 Jan 14.

PMID:
18248945
42.

A latent variable modeling approach to identifying subtypes of serious and violent female juvenile offenders.

Odgers CL, Moretti MM, Burnette ML, Chauhan P, Waite D, Reppucci ND.

Aggress Behav. 2007 Jul-Aug;33(4):339-52.

PMID:
17593559
43.

Cluster B personality pathology in incarcerated girls: structure, comorbidity, and aggression.

Burnette ML, South SC, Reppucci ND.

J Pers Disord. 2007 Jun;21(3):262-72.

PMID:
17536939
44.
45.

Understanding the risk factors for violence and criminality in women: the concurrent validity of the PCL-R and HCR-20.

Warren JI, South SC, Burnette ML, Rogers A, Friend R, Bale R, Van Patten I.

Int J Law Psychiatry. 2005 May-Jun;28(3):269-89.

PMID:
15923037
46.

A prospective study of assault against staff by youths in a state psychiatric hospital.

Ryan EP, Hart VS, Messick DL, Aaron J, Burnette M.

Psychiatr Serv. 2004 Jun;55(6):665-70.

PMID:
15175464
47.

Psychopathy in women: structural modeling and comorbidity.

Warren JI, Burnette ML, South SC, Chauhan P, Bale R, Friend R, Van Patten I.

Int J Law Psychiatry. 2003 May-Jun;26(3):223-42. No abstract available.

PMID:
12689623
48.

Personality disorders and violence among female prison inmates.

Warren JI, Burnette M, South SC, Chauhan P, Bale R, Friend R.

J Am Acad Psychiatry Law. 2002;30(4):502-9.

PMID:
12539904
49.
50.

Eye movement desensitization: three unusual cases.

Spates CR, Burnette MM.

J Behav Ther Exp Psychiatry. 1995 Mar;26(1):51-5.

PMID:
7642761

Supplemental Content

Loading ...
Support Center